Yaoxing Huang mainly focuses on Virology, Antibody, Immunology, Virus and Genotype. His Virology study combines topics in areas such as Phenotype, Pandemic, DNA vaccination and Chemokine receptor binding. His work on Antigen, T cell, Dendritic cell and Antigen presentation as part of general Immunology study is frequently connected to Multicenter AIDS Cohort Study, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Virus research is multidisciplinary, relying on both Transmission and Peptide sequence. His Genotype research includes elements of Coreceptor activity, CXCR4, Receptor, Viral replication and Allele. His Coreceptor activity study combines topics from a wide range of disciplines, such as V3 loop, Chemokine Receptor Gene, Viral entry, CCR5 receptor antagonist and Chemokine receptor CCR5.
The scientist’s investigation covers issues in Virology, Antibody, Immunology, Virus and Neutralization. His Virology research incorporates themes from Potency, DNA vaccination and Immunogenicity. His biological study spans a wide range of topics, including Pandemic, Immunity and Severe acute respiratory syndrome coronavirus 2.
His work in Immunology tackles topics such as In vivo which are related to areas like Electroporation and Cell. In his research on the topic of Virus, Genotype is strongly related with Chemokine receptor. The concepts of his Neutralization study are interwoven with issues in Mutation and Gene.
Yaoxing Huang focuses on Antibody, Virology, Severe acute respiratory syndrome coronavirus 2, Neutralization and Monoclonal antibody. His study in Antibody is interdisciplinary in nature, drawing from both Pandemic and Glycan. His Virology study incorporates themes from In vitro and Immunity.
The Severe acute respiratory syndrome coronavirus 2 study combines topics in areas such as Protease, Neuroscience, Coronavirus and 2019-20 coronavirus outbreak. His research in Neutralization intersects with topics in Receptor and Gene. In his study, Transmission is inextricably linked to Mutation, which falls within the broad field of Monoclonal antibody.
Antibody, Virology, Monoclonal antibody, Severe acute respiratory syndrome coronavirus 2 and Neutralization are his primary areas of study. He studies Epitope, a branch of Antibody. Yaoxing Huang has included themes like In vitro, Potency and Coronavirus in his Epitope study.
His Severe acute respiratory syndrome coronavirus 2 research incorporates elements of Neutralizing antibody and 2019-20 coronavirus outbreak. Transmission is closely connected to Mutation in his research, which is encompassed under the umbrella topic of Neutralization. His work investigates the relationship between Transmission and topics such as Virus that intersect with problems in Chemokine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
Tatjana Dragic;Virginia Litwin;Graham P. Allaway;Scott R. Martin.
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Yaoxing Huang;William A. Paxton;Steven M. Wolinsky;Avidan U. Neumann.
Nature Medicine (1996)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Pengfei Wang;Manoj S. Nair;Lihong Liu;Sho Iketani;Sho Iketani.
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Lihong Liu;Pengfei Wang;Manoj S. Nair;Jian Yu.
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.
Pengfei Wang;Ryan G. Casner;Manoj S. Nair;Maple Wang.
Cell Host & Microbe (2021)
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
Leondios G. Kostrikis;Yaoxing Huang;John P. Moore;Steve M. Wolinsky.
Nature Medicine (1998)
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.
Liuliu Yang;Yuling Han;Benjamin E. Nilsson-Payant;Vikas Gupta.
Cell Stem Cell (2020)
Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
J. P. Moore;J. A. Mckeating;Yaoxing Huang;A. Ashkenazi.
Journal of Virology (1992)
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
Pengfei Wang;Manoj S Nair;Lihong Liu;Sho Iketani;Sho Iketani.
Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.
Viviana Simon;Veronique Zennou;Deya Murray;Yaoxing Huang.
PLOS Pathogens (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: